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Abstract 
 
Nitropolycyclic aromatic hydrocarbons are ubiquitous in the environment, and many compounds of this 
family are carcinogenic.  6-Nitrochrysene, a representative member of this group, is a suspected human 
carcinogen that has been shown to cause lung, breast, and other forms of cancer in rodents.   It is believed 
that this derivative of chrysene causes cancer by forming DNA adducts, which, in turn, induce mutations 
in critical gene sequences.  The goal of my research is to synthesize one or more of the major DNA 
adducts formed by 6-nitrochrysene, which will be introduced in DNA in order to study their biological 
effects.   
 
The initiation step of the multi-step process that leads to cancer involves mutations in DNA via erroneous 
replication, which occurs when the body is unable to repair certain DNA damages.  Accumulation of 
these mutations in critical genes triggers a series of biological events, ultimately making the cell an 
outlaw.  Usually, there are specific processes the cell employs to repair DNA damages.  Cancer-causing 
agents, such as 6-nitrochrysene, are metabolically activated in a cell to electrophilic species, which induce 
specific DNA damages resulting in a high frequency of mutations.   
 
Understanding exactly how 6-nitrochrysene causes mutations will provide insight into how cancer by this 
chemical is initiated.    In order to accomplish this, one must synthesize the damaged nucleoside and 
incorporate it into a DNA fragment.  In this thesis, two new schemes are presented to prepare the 6-
nitrochrysene-damaged DNA fragments.   
 
I have completed the synthesis of the appropriately protected C8-dG 6-nitrochrysene adduct and its 
subsequent incorporation into an oligonucleotide by using a solid phase synthesis approach.  This 
adducted oligonucleotide will be used for structural and biological studies.   
 
xii 
 
I have also developed and refined a synthetic route towards the N
2
-dG adduct.  In this novel scheme, the 
precursor to the Buchwald-Hartwig coupling has been prepared, and the chrysene derivative is nearly 
complete.  The subsequent steps are expected to proceed in good to excellent yield. 
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CHAPTER I 
 
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
2 
 
1.1 DNA Damages 
 
DNA acts as a carrier for all of the genetic information in an organism.  When a cell undergoes 
replication, it is critical that the DNA undergoes faithful replication and pass the genetic information to 
the subsequent generation.  The process of DNA replication is semi-conservative, since each strand of the 
double helix can act as a template for a new strand.  This replication method gives the next generation one 
of the old strands, along with a newly synthesized strand.  Due to the high fidelity of DNA polymerase, 
this process takes places with a very high degree of accuracy.  However, the few errors that do occur 
allow for the mutations necessary to produce a variety of species through evolution.
[1] 
 
DNA possesses a number of nucleophilic centers in its structure and is therefore very susceptible to attack 
by various agents.  These agents include, but are not limited to, ultraviolet light, natural and man-made 
chemicals, ionizing radiation, and reactive oxygen species.
[2]
  All of these agents can induce DNA 
damages.  The process by which the damage occurs can either be through direct reaction of the agent with 
DNA, or through metabolic processes within the cell which activate the agent and enable it to react with 
DNA.  Chemical carcinogens are often metabolized by the cellular enzymes and are largely excreted. 
However, some of these metabolites may still react with DNA.
 [3-6]
 
 
If the cell is damaged, multiple pathways are pursued to rectify the damage or to avoid further damage to 
the organism.  Among these is apoptosis, the process of programmed cell death.  This can occur if the 
damage is great enough to induce a double strand break.  There is also cell cycle checkpoint activation, 
which serves to halt the cell cycle at G1.  Arrest of cell replication can occur through a variety of 
pathways, but it primarily proceeds through ubiquitination of key phosphatases to mark them for 
degradation.  This triggers a series of cellular activities which serve to prevent the cell from transitioning 
to S phase.
[3] 
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Once damaged, there are a variety of repair 
mechanisms which the cell can also utilize.  Among 
these are nucleotide excision repair (NER) and base 
excision repair (BER) pathways.  BER is usually 
employed for small, non-helix-distorting lesions 
within DNA (Figure 1).
[7]
  In this process, DNA 
glycosylases turn the damaged strand of the double 
helix to face outside.  Then the N-glycosidic bond of 
the damaged base is cleaved, leaving an AP 
(apurinic/apyrimidic) site.  The AP site is cleaved 
from the phosphodiester backbone, and the resulting 
single-strand break is repaired either by short-patch 
(single nucleotide) or long-patch (2-10 nucleotides) 
BER.  Current studies are attempting to determine what may be the deciding factor between these two 
pathways, but as of now, no decisive conclusion has been reached.  Pol β is the primary DNA polymerase 
that repairs the strand in the short-patch pathway, although in 
its absence, pol γ can take over.  In the long-patch pathway, 
pol δ and pol ε are the primary DNA polymerases; it should be 
noted that pol β can also take part in long-patch repair.  In 
contrast, NER is employed to repair bulky or helix-distorting 
DNA adducts (Figure 2).
[8]
  NER is initiated when a helical 
distortion is noted or when RNA polymerase stalls at some 
type of DNA lesion during transcription.  The former initiation 
is referred to as GG-NER (global genomic NER) while the 
latter is referred to as TC-NER (transcription-coupled NER).  
4 
 
They differ only in their methods of identifying DNA damages.  Thereafter, both pathways undergo the 
same process.  DNA is unwound and a single-strand gap of 25-30 nucleotides around the damage is 
excised.  DNA polymerases (usually pol δ, ε, and/or κ) are recruited to repair the strand, following which 
a ligase seals the nicks in the strand.   
 
There is also a series of translesion synthesis (TLS) polymerases, which aid a cell in bypassing DNA 
lesions.
[4,9]
  They restart stalled replications sites, but the major consequence of these polymerases are 
their higher rates of errors and aptitude for introducing mutations in the DNA sequence.
[9a,c]
  The five 
known eukaryotic polymerases are Rev1, pol ζ, pol η, pol κ, and pol ι.  These (with the exception of the 
pol ζ, which is a B family polymerase) are part of the Y family of polymerases which are modified with 
specialized structures to allow for the ability to read through bulky lesions, insert bases opposite them, 
and carry out further extension.
[9b]
  Their function is not to repair the damage, but to simply bypass the 
lesion.  This allows for survival through DNA replication as opposed to maintaining the accuracy of the 
genetic information.  Based on this, it is not surprising that DNA damage tolerance is often a mutagenic 
process.
[9d]
  Replicative DNA polymerases make one error in 10
6
-10
8
 bases, while TLS polymerases make 
errors once every 10-10
3
 bases.  This reduced fidelity is likely due in part to some of the polymerases not 
using canonical Watson-Crick base pairing (ex. pol ι and Rev1), whereas some do not undergo an induced 
fit upon nucleotide binding and may involve a limited contact with the template base.  Altogether, cells’ 
development of TLS polymerases to bypass DNA lesions and allow for restarting of stalled replication 
forks comes at the cost of higher mutational frequencies.  Elaborate regulatory mechanisms are in place to 
limit the amount of mutations introduced during replication and this subject is still being investigated.
[9e] 
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1.2 Polycyclic Aromatic Hydrocarbons 
Polycyclic aromatic hydrocarbons (PAHs) are a 
family of compounds comprising hydrocarbons in 
multiple aromatic rings (Figure 3).
[6]
  This family 
has been studied extensively and a number of its 
members have been associated with various 
carcinogenic effects in biological systems.
[10]
  The 
first chemical carcinogen discovered was benzo[a]pyrene, one of the many chemical carcinogens present 
in cigarette smoke.  Since then, the EPA has classified several PAHs as probable human carcinogens: 
benz[a]anthracene, benzo[a]pyrene, benzo[b]fluoranthene, benzo[k]fluoranthene, chrysene, 
dibenz[a,h]anthracene, and indeno[1,2,3-cd]pyrene.  All of these are on the EPA’s list of priority 
pollutants and are often targeted for measurement in environmental samples.
[11,12]
  
 
A subfamily of the PAHs is the nitro-PAHs.  Nitropolycyclic aromatic hydrocarbons were first studied 
intensively when 4-nitroquinoline-1-oxide (4-NQO) was reported as a potent carcinogen.
[11]
  After the 
finding that this compound is carcinogenic, a number of other nitro-PAHs were found to be carcinogenic.  
In fact, the nitrated versions of the original PAHs proved to be even more carcinogenic than their un-
substituted counterparts.  Members of this subfamily are easily found in various environmental samples, 
thereby warranting the extensive studies on their potential biological effects. 
 
The original PAHs are capable of reacting with nitrogen oxides to form NO2-PAHs; this was first reported 
by Pitts et al
[11a]
 and Jager.
[11b]
  These reactions proceed under conditions akin to polluted air and 
combustion processes.  As such, it is not surprising that the nitro-PAHs are commonly found in diesel 
exhaust and cigarette smoke, along with coal fly ash, industrial waste, and refined oil products.  
Additionally, some have also been found in the charred portion of certain grilled foods.  As is clearly 
demonstrated, human exposure to these compounds can occur through a variety of routes. 
6 
 
 
Multiple studies focusing on the public exposure to these carcinogens determine that several occupational 
groups are at a considerably higher risk for developing associated cancers.
[5]
  These include coke oven 
workers, steelworkers, furnace workers, asphalt workers, and the general public in cities with a high 
degree of air pollution.  The occupational risks are directly associated with the complex mixtures 
containing PAHs that these workers encounter on a day-to-day basis, which may include coal tar pitch, 
coke oven tar, and crumb rubber asphalt.
[6]
  As expected, smokers also belong to a high exposure 
population. 
 
1.3 Metabolic Activation of 6-Nitrochrysene 
 
Human exposure to these carcinogens occurs primarily through inhalation but also by ingestion and 
dermal contact.  Once introduced into the body, the polycyclic aromatic hydrocarbons are capable of 
being biologically activated through metabolism.
[13,14]
  The process of metabolism of each of the PAHs 
usually results eventually in what is referred to as the “ultimate carcinogen”, the most reactive and 
mutagenic derivative of the PAH.
[13a]
  Usually, the original PAH – such as pyrene or chrysene – is not 
nearly as carcinogenic as some of its derivatives. 
 
Chrysene in particular is notably less carcinogenic than its nitrated from.
[13b-d]
  It is commonly found in 
exhaust mixtures of high temperature, such as coke oven exhaust or consumed engine oil.  Although the 
abundance of 6-nitrochrysene is far reduced compared to other members of its family, it is the most potent 
tumor-inducing agent in animal studies among all tested nitroaromatic compounds.
[13]
   It also exhibits 
one of the highest carcinogenic potencies in experimental animals among a broad spectrum of PAH 
metabolites. 
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There are various pathways of metabolic activation 
for a given PAH.  These include (1) metabolic 
oxidation using cytochrome P450 to form PAH 
radical cations, (2) creation of PAH-o-quinones via 
dihydrodiol dehydrogenase, and (3) formation of 
dihydrodiol epoxides via cytochrome p450 enzymes.  Most commonly, metabolic activation occurs 
through the formation of bay-region dihydrodiol epoxides.
[15]
  These species are extremely reactive and 
can covalently bind to DNA to form the DNA damages discussed earlier.  The PAH diol epoxides 
(PAHDE) are further classified into groups based on the surrounding rings.  There can be fjord, bay, and 
k-region modifications (Figure 4).
[16]
  Both the bay and fjord complexes can form PAHDEs while the K 
region forms (predominantly) the epoxide (Figure 5).  The PAHs with a fjord region typically show a 
high rate of tumorigenicity.  Due to the placement of the epoxide and hydroxyl moieties, the planarity of 
the ring system cannot be maintained.  These species are very 
reactive and tend to preferentially bind to adenines.  In 
contrast, PAHs with a bay region are less reactive than the 
fjord region compounds.  Due to the location of the hydroxyl 
and epoxide moieties on the outer ring, the entire compound 
is able to remain planar.  As a consequence of reduced 
activity, these derivatives are generally seen binding to 
guanine bases upon DNA adduct formation.   
 
The metabolic pathway of 6-NC is shown in Figure 6 (adapted from Boyiri et al.).
[14c]
  There are two 
predominant routes though which 6-NC can be metabolized: dihydroxylation and reduction.
[17]
  The 
dihydroxylative pathway produces a variety of activated products through combinations of ring 
epoxidation and nitroreduction.  The ring epoxidation occurs rapidly after dihydroxylation due to the 
availability of the double bond in the ring that lost its aromaticity.   
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The diol-epoxides comprise the set of the most reactive 6-nitrochrysene derivatives.  These have been 
associated with multiple cases of malignant liver and lung cancers.
[14]
  The other route occurs through 
reduction, producing N-hydroxyaminochrysene.  This derivative is capable of forming a variety of 
adducts as listed in Figure 6.  Among these, are the N-(deoxyguanosine-8-yl)-6-aminochrsyene (C8-dG 
adduct), 5-(deoxyguanosine-N
2
-yl)-6-aminochrysene (N
2
-dG adduct), and N-(deoxyinosin-8-yl)-6-
aminochrysene (C8-dI adduct).  The latter adduct is believed to arise from deamination of the C8-dG 
adduct.   
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1.4 Buchwald-Hartwig Palladium Catalyzed Coupling Reactions 
 
The key reaction in these syntheses is the formation of a C-N bond connecting the polycyclic aromatic 
hydrocarbon to the guanine base (see Reference 18 for a list of syntheses that employ this approach for 
similar substrates).  This is accomplished via a Buchwald-Hartwig coupling reaction (Figure 7
[19]
).  This 
produces a new carbon-nitrogen bond between the carcinogen and the DNA base.
[20]
   
 
 
 
The attachment points for each adduct vary.  As such, the coupling reactants are modified to suit 
individual adducts.  The C8-dG adducts are connected at the C8 position of the guanine base.  The aryl 
carcinogen undergoes amination and the guanine base is brominated.  To create the N
2
-dG adduct, the aryl 
carcinogen must have a leaving group such as a halogen or trifluoromethanesulfonate (triflate) to react 
with the free amine already present on the guanine base (Figure 8). 
 
 
 
The general mechanism for this reaction was originally thought to be akin to other palladium-catalyzed 
coupling reactions, which includes: oxidative insertion and reductive elimination, and the coupled C-N 
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bond is formed.
[19, 20a]
  This implies that the original palladium catalyst begins in the zero oxidation state.  
The first step of the catalytic cycle is oxidative insertion of the aryl halide or triflate, resulting in the 
palladium increasing to a +2 oxidation state.  Upon direct attack of the amine on the palladium, the halide 
or triflate leaves and react with the strong base present in solution.  Finally, upon reductive elimination, 
the palladium catalyst returns to its zero oxidation state while producing the desired C-N bond.  This is 
the process presented in older literature such as Singh et al.
[21]
 
 
More recently, the Hartwig, Blackmond, and Buchwald groups published a correction to this 
mechanism.
[22]
  After several structural and kinetic studies,  they posited the mechanism shown in Figure 
9.  Here, there is a “dead-end step” with the equilibrium forming Pd(BINAP)2.  In situ, this complex 
forms and later dissociates to enter the catalytic cycle.  Based on their studies, they believe that this is the 
palladium source that undergoes oxidative addition with the aryl halide.  Then, upon addition of the base, 
the catalytic cycle proceeds as expected with the coordination of the amine with the Pd(II) complex.  This 
is, of course, followed by reductive elimination of the desired product and regeneration of the Pd(BINAP) 
complex which can resume the catalytic 
cycle. 
 
The reactions require both a chelating 
ligand and an appropriate palladium 
catalyst along with a strong base.  
Originally, the purpose of the strong base 
was to avoid the use of aminotin species, 
which are heat and moisture-sensitive 
species.  The strong base most commonly 
used is sodium tert-butoxide and this is 
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the base used in all the syntheses presented here.  The ligand and metal catalyst work together in a 
complex in situ.  The chelating ligand chosen for the coupling of guanine with varying chrysene 
derivatives was 2,2’-bis(diphenylphosphino)-1,1’-binapthyl (BINAP), depicted in Figure 10.  Finally, the 
palladium catalyst used was tris(dibenzylideneacetone)dipalladium(0), Pd2dba3.  These two choices are 
the most common choices for couplings of this nature, and were the first chosen for these syntheses.  
Since the reactions proceeded in good yield, other combinations of bases, ligands, and catalysts were not 
attempted. 
 
 
 
1.5 Solid-Phase Oligonucleotide Synthesis 
 
Ultimately, the DNA adducts prepared must undergo solid-phase oligonucleotide synthesis.
[23]
  This is a 
process to create a very specific oligonucleotide, containing the specially prepared DNA adduct 
monomer.  Generally speaking, the oligomer chosen for my work was taken from the p53 tumor 
suppressor gene, and the length of the oligomer chosen was based on the type of biological study that will 
be performed.  However, in order to properly incorporate the DNA adduct into the oligonucleotide, it 
must be prepared with appropriate protecting groups.   
 
Specifically in terms of a deoxyguanosine adduct, the 3’- and 5’-OH groups must be protected along with 
the N
2
 amino group (Figure 11).  It should be noted that, in the case of the N
2
-dG adducts, the N
2
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protection is omitted since the carcinogen is present at that position.  The 5’-OH must be protected with 
an acid labile group.  Traditionally, this has always been an MMtr
[24a]
 or DMTr
[24b]
 group.  Since the 
DMTr protecting group has far more selectivity towards primary hydroxyls over secondary hydroxyls, its 
use has become more prevalent.  The 3’-OH group is always protected with a phosphoramidite group.[23] 
This group is specific for oligonucleotide synthesis and allows for the generation of the phosphodiester 
linkage between the ribose sugars and is capable of undergoing oxidation to produce the sugar-phosphate 
backbone.  Finally, the N
2
 amine on the guanosine base must be protected with a base labile group.
[23]
  
Historically, this was accomplished via an isobutyryl protection.
[25]
  In recent years, a shift towards a 
DMF acetal protection has occurred since the latter group is far more labile during the deprotection step 
of the solid phase synthesis.
[26]
  In the example presented in Figure 11, a DMF acetal group is present on 
the undamaged deoxyguanosine base. 
 
Upon appropriate protection of the 
DNA adduct, the singular base is put 
through solid-phase oligonucleotide 
synthesis.  This is a cyclic process 
that couples a series of individual 
bases to each other, resulting in the 
desired oligomer.
[23]
  As represented 
in Figure 12, the cycle begins with a protected base.  The first step is detritylation, where the DMTr group 
on the 5’-OH is removed with a dilute acid.  The free hydroxyl is then able to undergo coupling with the 
next base.  This occurs through nucleophilic attack on the phosphorus of the incoming base and loss of a 
diisopropyl amine.  The resulting bond is a phosphate linkage between two ribose sugars.  The coupling 
step is generally expected to proceed in excellent yield (in the vicinity of 99.5%), but it is unreasonable to 
expect full conversion.  As such, it is expected that there are some remaining 5’-OH groups that haven’t 
coupled with the next base in the sequence.  They cannot be allowed to continue to the next step in the 
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cycle, otherwise, they would from an oligomer with a deletion mutation.  To avoid this, a capping step is 
introduced at this point in the cycle.  Capping is essentially a process to “protect” the 5’-OH group, and 
prevent it from reacting further.  It is usually accomplished via an N-methylimidazole or acetate group.  
The final step is oxidation of the phosphorus in the newest base was introduced to the oligomer; as seen in 
Figure 12, a double bond to an additional oxygen atom is observed.  Once this has been completed, the n-
mer will continue onto the next cycle for introduction of the next base.  This process continues until the 
desired oligomer has been produced. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
14 
 
 
 
 
 
 
CHAPTER II 
 
 
SYNTHESIS OF THE C8 
PHOSPHORAMIDITE MONOMER OF      
8-(N-6-AMINOCHRYSENE)-N2-DMF-5’-
O-(4,4’-DIMETHOXYTRITYL)-2’-
DEOXYGUANOSINE 
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2.1 Scheme for the 6-NC C8-dG Phosphoramidite Monomer 
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2.2 Materials and Methods 
 
MATERIALS 
 
Bulk solvents and chemicals were purchased either from Sigma Aldrich (St. Louis, MO) or Fisher 
Scientific (Clifton, NJ).  Deuterated solvents were purchased from Cambridge Isotope Laboratories 
(Andover, MA).  The 2’-deoxyguanosine was purchased from Berry and Associates (Dexter, MI).  Every 
reagent used was obtained in the highest purity available.  Both flash chromatography silica gel and 
gravitational chromatography silica gel were purchased from Sorbent Technology (Norcross, GA).   
 
SPECTROSCOPIC METHODS 
 
NMR:  NMR spectra were recorded as indicated on a Bruker 300, 400, or 500 MHz spectrometer.  
1
H 
chemical shifts are reported in parts per million relative to the residual chloroform (δ 7.26 ppm) or 
dimethyl sulfoxide (δ 2.50 ppm) peak.  The 13C-NMR values were referenced to the residual chloroform 
(δ 77.1 ppm) or dimethyl sulfoxide (δ 39.52 ppm) peak.  The 31P-NMR shifts are reported as obtained 
from the spectrometer.  The 
19
F-NMR values are reported as obtained from the spectrometer.  
1
H-NMR 
shifts are reported as chemical shift δ, multiplicity(s, singlet; d, doublet, t, triplet; q, quartet; m, multiplet; 
br., broad), relative integral, and assignment. 
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PROCEDURES 
 
6-Nitrochrysene (2) – In a 50 mL round bottom flask equipped with a stirbar was taken chrysene (1, 1.00 
g, 4.384 mmol) in glacial acetic acid (28 mL).  The solution was stirred briefly in an oil bath at 40 
o
C.  To 
it a solution of fuming nitric acid (0.8 mL, 18.019 mmol) and concentrated sulfuric acid (1.0 mL, 18.760 
mmol) in glacial acetic acid (8 mL) was slowly added dropwise.  The reaction was allowed to stir for 20 
mins at 40
o
C; within 5-10 mins, the reaction mixture turned yellow.  After 20 mins, the solution was 
allowed to cool to room temperature and the solution was filtered.  The precipitate was washed with 
acetic acid and allowed to dry over vacuum for 2 h.  Following this, the compound was further dried in an 
oven for 30 mins to afford the pure compound as a pale yellow solid (1.0701 g, 89% yield). 
 
1
H-NMR (400 MHz, DMSO-d6) δ ppm 7.68-8.01 (m, 4H, C1-H, C2-H, C16-H, C17-H), 7.93 (m, 2H, C12-H, 
C15-H), 8.37 (t, 1H, C6-H), 8.89-8.95 (m, 1H, C11-H), 9.01 (t, 1H, C18-H), 9.17 (m, 1H, C3-H), 9.60 (s, 1H, 
C9-H) 
 
6-Aminochrysene (3) – In a 25 mL round bottom flask quipped with a stirbar was taken 2 (100 mg, 0.366 
mmol).  The flask was placed under a N2 atmosphere, and to it was added ethanol (8.5 mL).  The flask 
was purged with N
2
 for 30 mins.  At this time, hydrazine monohydrate (0.6 mL, 5.803 mmol) was added 
to the flask, and the flask was purged for an additional 30 mins.  After this, 10% wt palladium on carbon 
(1.3 mg, 0.0265 mmol) was added to the flask, and the reaction was heated at reflux for 15 h.  After this 
time, the reaction flask was allowed to cool to room temperature, and the solvent was evaporated.  The 
crude product was loaded onto a silica gel plug and the desired compound eluted in neat dichloromethane.  
The solvent was removed via rotary evaporation to afford the pure compound as a pale yellow solid (70.6 
mg, 79% yield). 
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1
H-NMR (400 MHz, DMSO-d6) δ ppm 6.03 (s, 2H, NH2), 7.60-7.78 (m, 5H, C1-H, C2-H, C9-H, C16-H, 
C17-H), 7.95 (m, 1H, C11-H), 8.12 (m, 2H, C12-H, C15-H), 8.59-8.67 (dd, 1H, C6-H), 8.89 (d, 1H, C18-H), 
8.95 (d, 1H, C3-H) 
 
13
C-NMR (101 MHz, DMSO-d6) δ ppm 100.77, 121.08, 122.24, 122.72, 123.41, 123.69, 124.31, 124.60, 
126.13, 126.54, 126.90, 127.42, 128.96, 129.33, 131.50, 131.67, 132.98, 144.51. 
 
8-Bromo-2’-deoxyguanosine (5) – In a 500 mL Erlenmeyer flask equipped with a stirbar was taken 2’-
deoxyguanosine monohydrate, 4 (6.50 g, 24.323 mmol) suspended in 80% aqueous acetonitrile (300 mL) 
at room temperature.  Freshly recrystallized N-bromosuccinimide (6.493 g, 36.483 mmol) was added to 
the stirring mixture in three aliquots over 30 mins.  The reaction mixture was then stirred for an additional 
30 mins.  After this time, the reaction mixture was filtered through a Büchner funnel.  The product was 
washed with acetone to give 7.504 g (89% yield) of the product as a white flaky solid.   
 
1
H-NMR (400 MHz, DMSO-d6) δ ppm 2.07-2.13 (ddd, 1H, C13-H), 3.12-3.19 (ddd, 1H, C13-H’), 3.33 (br. 
s, 1H, O17-H), 3.48-3.52 (dd, 1H, C18-H), 3.60-3.64 (dd, 1H, C18-H’), 3.78-3.82 (q, 1H, C12-H), 4.38-4.41 
(m, 1H, C16-H), 4.84 (br. s, 1H, O19-H), 6.14-6.17 (t, 1H, C14-H), 6.48 (br. s, 2H, N10-2H), 10.78 (s, 1H, 
N1-H) 
 
13
C-NMR (101 MHz, DMSO-d6) δ ppm 36.46 (C13), 62.05 (C18), 71.03 (C12), 85.06 (C14), 87.90 (C16), 
117.49 (C5), 120.53 (C7), 151.98 (C4), 153.32 (C2), 155.42 (C6) 
 
8-Bromo-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine (6) – In a 25 mL round bottom flask 
equipped with a stirbar was taken 5 (907 mg, 2.62 mmol) and imidazole (852 mg, 12.52 mmol) in dry 
DMF (10 mL) at room temperature.  To the stirring reaction mixture was added tert-butyldimethylsilyl 
chloride (1.085 g, 7.2 mmol).  The solution turned transparent within 5 mins and was allowed to continue 
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stirring for 8 hrs.  Once this time elapsed, the reaction was quenched with methanol.  The solution was 
evaporated and diluted with deionized water (25 mL) and methylene chloride (25 mL).  The layers were 
separated and the aqueous layer extracted with methylene chloride (2 x 25 mL).  The crude product was 
purified by silica gel flash column chromatography with a step gradient of methanol (0-10%) in 
methylene chloride as the mobile phase.  The product was isolated as a white solid (1.42 g, 94% yield). 
 
1
H-NMR (400 MHz, DMSO-d6) δ ppm -0.04 (s, 3H, C23-3H), -0.02 (s, 3H, C24-3H), 0.09 (s, 6H, C29-3H, 
C30-3H), 0.81 (s, 9H, C32-3H, C33-3H, C34-3H), 0.87 (s, 9H, C25-3H, C26-3H, C27-3H), 2.10-2.16 (ddd, 1H, 
C13-H), 3.35-3.41 (ddd, 1H, C13-H’), 3.61-3.67 (m, 1H, C12-H), 3.73-3.79 (m, 2H, C18-2H), 4.58 (m, 1H, 
C16-H), 6.13-6.16 (t, 1H, C14-H), 6.46 (br. s, 2H, N10-2H), 10.87 (s, 1H, N1-H) 
 
13
C-NMR (101 MHz, DMSO-d6) δ ppm -5.50 (C29, C30), -4.94 (C23), -4.77 (C24), 17.63 (C31), 17.90 (C22), 
25.63 (C32, C33, C34), 25.69 (C25, C26, C27), 36.07 (C13), 62.82 (C18), 72.38 (C12), 84.68 (C14), 87.12 (C16), 
117.46 (C5), 120.40 (C7), 152.10 (C4), 153.38 (C2), 155.46 (C6) 
 
O
6
-Benzyl-8-bromo-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine (7) – In a 50 mL round 
bottom flask equipped with a stirbar was taken 6 (1.0 g, 1.74 mmol) and triphenylphosphine (800 mg, 
3.04 mmol).  The flask was placed under an N2 atmosphere, and to it was added dry dioxane (20 mL).  To 
the stirring reaction mixture at room temperature, benzyl alcohol (0.316 mL, 3.05 mmol) was added.  
Diisoproyl azodicarboxylate (0.600 mL, 3.09 mmol) was added dropwise to the stirring mixture, which 
turned to a transparent yellow within 15 mins.  The reaction was allowed to continue stirring at room 
temperature for 8 h under the N2 atmosphere.  After this time, the solvent was evaporated.  The crude 
compound was purified by silica gel flash column chromatography with a step gradient of ethyl acetate 
(0-15%) in hexanes as the mobile phase.  The product was isolated as a light yellow solid (0.903 g, 78 % 
yield).   
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1
H-NMR (400 MHz, CDCl3) δ ppm -0.03 (s, 3H, C37-3H), 0.01 (s, 3H, C38-3H), 0.14 (s, 6H, C29-3H, C30-
3H), 0.84 (s, 9H, C39-3H, C40-3H, C41-3H), 0.93 (s, 9H, C31-3H, C32-3H, C33-3H), 2.13-2.18 (ddd, 1H, C13-
H), 3.50-2.56 (ddd, 1H, C13-H’), 3.67-3.71 (dd, 1H, C17-H), 3.83-3.93 (m, 2H, C12-H, C17-H), 4.78(dt, 1H, 
C16-H), 5.51 (s, 2H, C19-2H), 6.25 (t, 1H, C14-H), 6.28 (br. s, 2H, N10-2H), 7.28-7.36 (m, 3H, C21-H, C23-
H, C25-H), 7.46 (m, 2H, C22-H, C24-H) 
 
13
C-NMR (101 MHz, CDCl3) δ ppm -5.45 (C37, C38), -4.66 (C29, C30), 18.00 (C36), 18.30 (C28), 21.90 (C39, 
C40, C41), 25.80 (C31, C32, C33), 36.41 (C13), 62.64 (C17), 68.10 (C19), 72.30 (C12), 85.71 (C16), 87.37 (C14), 
116.42 (C5), 126.90 (C7), 128.00 (C23), 128.27 (C25), 128.33 (C21), 128.47 (C24), 128.51 (C22), 136.12 
(C20), 154.41 (C4), 158.38 (C2), 159.81 (C6)  
 
O
6
-Benzyl-8-bromo-3',5'-O-bis(tert-butyldimethylsilyl)-N
2
-dimethoxytrityl-2'-deoxyguanosine (8) – In a 
25 mL round bottom flask equipped with a stirbar was taken 7 (1.20 g, 1.80 mmol) in dry pyridine (15 
mL).  To this, was added some crystals of 4-dimethylaminopyrine.  4,4-Dimethoxytrityl chloride (0.92 g, 
2.70 mmol) was added to the solution at room temperature and the reaction mixture was allowed to 
continue stirring for 12 hrs.  The reaction was checked for completion by TLC (80/20 Hexanes/EtOAc, 
v/v). The solvent was evaporated and purified by aluminum oxide column chromatography with a step 
gradient of ethyl acetate (0-10%) in hexanes as the mobile phase.  The product was isolated as a 
transparent solid (1.58 g, 91% yield). 
 
1
H-NMR (400 MHz, DMSO-d6) δ ppm -0.11 (s, 3H, C48-3H), -0.05 (s, 3H, C47-3H), 0.10 (s, 6H, C56-3H, 
C57-3H), 0.77 (s, 9H, C53-3H, C54-3H, C55-H), 0.87 (s, 9H, C49-3H, C50-3H, C51-3H), 3.32 (s, 2H, N10-H, 
C12-H), 3.51-3.56 (m, 2H, C13-H, C18-H), 3.68 (s, 6H, C41-3H, C43-3H), 3.72-3.76 (m, 2H, C16-H, C18-H), 
4.81 (br. s, 2H, C58-2H), 6.07 (t, 1H, C14-H), 6.79-6.85 (d, 4H, C26-H, C28-H, C36-H, C38-H), 6.87-6.91 (m, 
1H, C62-H), 7.14-7.24 (m, 6H, C30-H, C34-H, C60-H, C61-H, C63-H, C64-H), 7.26-7.28 (d, 4H, C25-H, C29-H, 
C35-H, C39-H), 7.30-7.32 (m, 3H, C31-H, C32-H, C33-H) 
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13
C-NMR (101 MHz, DMSO-d6) δ ppm -4.92 (C57), -4.79 (C56), -4.16 (C48), -4.02 (C47), 18.43 (C52), 
18.56 (C46), 26.33 (C53, C54, C55), 26.36 (C49, C50, C51), 35.83 (C13), 55.66 (C41, C43), 62.83 (C12), 67.64 
(C58), 70.24 (C18), 72.80 (C21), 85.95 (C16), 87.33 (C14), 113.57 (C26, C28, C36, C38), 115.63 (C5), 127.06 
(C7), 128.26 (C32), 128.68 (C60, C62, C64), 128.72 (C31, C33), 129.05 (C25, C29, C35, C39), 129.08 (C61, C63), 
130.37 (C30, C34), 136.72 (C59), 138.32 (C22, C24), 138.41 (C23), 146.41 (C2), 154.59 (C4), 157.66 (C6), 
158.37 (C27, C37) 
 
8-(N-6-Aminochrysene)-O
6
-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-N
2
-dimethoxytrityl-2'-
deoxyguanosine (9) – In a 25 mL round bottom flask equipped with a stirbar was taken 8 (531 mg, 0.548 
mmol), 6-aminochrysene (3, 200 mg, 0.822 mmol), tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3, 
20 mg, 0.0219 mmol), and rac-2,2’-bis(diphenylphosphino)-1,1’-binaphthyl (BINAP, 40 mg, 0.0636 
mmol), in dry toluene (5 mL).  The solution was degassed by purging argon for one hour.  The solution 
was then heated at 90
o
C for one hour.  At this point, sodium tert-butoxide (79 mg, 0.823 mmol) was 
added, and the solution heated at 100
o
C for an additional hour.   The reaction was cooled, diluted with 
ether (10 mL), and successively filtered through Celite®.  The filtrate was evaporated and purified by 
alumina oxide column chromatography with a step gradient of EtOAc (0-15%) in hexanes as the mobile 
phase.  The product was isolated as a dark yellow-green solid (354 mg, 57% yield).   
1
H-NMR (400 MHz, CDCl3) δ ppm -0.27 (s, 3H, CH3), -0.19 (s, 3H, CH3), 0.12 (s, 6H, 2 x CH3), 0.64 (s, 
9H, t-Bu-9H), 0.94 (s, 9H, t-Bu-9H), 2.26 (m, 1H, C2’-H), 2.88 (br. s, 1H, C2’-H), 3.80 (s, 6H, 2 x OMe), 
3.82-3.95 (m, 2H, C5’-2H), 4.15 (q, 1H, C3’-H), 4.50 (br. s, 1H, C4’-H), 5.08 (br. s, 2H, Bn-CH2), 6.10 (s, 
1H, N
2
-H), 6.22 (br. s, 1H, C1’-H), 6.80 (d, 4H, DMTr-4H), 7.14-7.25 (m, 9H, DMTr-9H), 7.29-7.44 (m, 
5H, OBn-5H), 7.57-7.74 (m, 4H, CR-4H), 7.91-8.01 (m, 2H, CR-2H), 8.11 (d, 1H, CR-H), 8.37 (br. s, 
1H, CR-H), 8.66 (d, 1H, CR-H), 8.77 (d, 1H, CR-H), 8.83 (d, 1H, CR-H), 9.52 (br. s, 1H, N
8
-H) 
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13
C-NMR (101 MHz, CDCl3) δ ppm -5.78, -5.70, -4.74, -4.58, 18.00, 18.23, 25.66, 25.81, 55.14, 55.23, 
63.15, 70.14, 72.59, 112.78, 112.81, 113.16, 120.88, 123.85, 126.29, 126.37, 127.51, 127.83, 128.12, 
128.23, 129.02, 129.11, 130.19, 130.25, 130.40, 131.44, 132.37, 158.00 
ESI-MS (positive mode): m/z calcd for C68H76N6O6Si2H
+
 1129.5, observed 1129.9 Da [M+H]
+
 
8-(N-6-Aminochrysene)-O
6
-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine (10) – In a 
100 mL round bottom flask equipped with a stirbar was taken 9 (1.976 g, 1.746 mmol).  The compound 
was dissolved in a minimal amount of methylene chloride (10 mL) and reacted with 0.01M methanolic 
HCl (20 mL, 0.175 mmol).  The mixture was stirred for 16 h and monitored by TLC (neat DCM).  Upon 
completion of the reaction, the solvent was evaporated and purified by silica gel flash column 
chromatography with a gradient of methanol (0-5%) in dichloromethane as the mobile phase.  The 
product was isolated as a yellow solid (0.9697 g, 67% yield). 
1
H-NMR (400 MHz, CDCl3) δ ppm -0.27 (s, 3H, CH3), -0.19 (s, 3H, CH3), 0.17 (s, 6H, 2 x CH3), 0.63 (s, 
9H, t-Bu-9H), 0.97 (s, 9H, t-Bu-9H), 2.40 (ddd, 1H, C2’-H), 3.15 (ddd, 1H, C2’-H), 3.85 (m, 1H, C5’-H), 
3.98 (m, 1H, C5’-H) , 4.17 (q, 1H, C4’-H), 4.64 (m, 1H, C3’-H), 4.78 (br. s, 2H, OBn-2H), 5.63 (br. s, 2H, 
N
2
-2H), 6.47 (t, 1H, C1’H), 7.28-7.36 (m, 3H, OBn-Ar-3H), 7.52 (d, 2H, OBn-Ar-2H), 7.61-7.75 (m, 4H, 
CR-4H), 7.93-7.99 (m, 2H, CR-2H), 8.14 (d, 1H, CR-H), 8.35 (br. s, 1H, CR-H), 8.67 (d, 1H, CR-H), 
8.79-9.00 (m, 2H, CR-2H), 9.48 (s, 1H, N
8
-H) 
13
C-NMR (101 MHz, CDCl3) δ ppm -5.93, -5.86, -4.87, -4.70, 17.86, 18.09, 25.49, 25.63, 39.16, 53.26, 
62.92, 67.99, 72.24, 77.06, 85.01, 87.85, 112.55, 113.37, 120.75, 121.46, 123.69, 125.21, 125.86, 126.14, 
126.17, 126.39, 126.89, 127.52, 127.86, 128.07, 128.11, 128.78, 130.23, 131.32, 132.22, 133.67, 136.89, 
148.58, 153.86, 157.04, 158.06 
ESI-MS (positive mode): m/z calcd for C47H58N6O4Si2H
+
 827.4, observed 827.7 Da [M+H]
+
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8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine (11) – In a 50 mL round 
bottom flask equipped with a stirbar was taken 10 (0.9697 g, 1.169 mmol) in anhydrous methanol (20 
mL).  The resulting solution was purged with N2 for 30 mins.  At this point, palladium black (125 mg, 
1.169 mmol) was added to the stirring solution.  The reaction was purged with H2 for an additional 2 h 
and then left to stir under a hydrogen atmosphere for 12 h.  The reaction mixture was monitored by TLC 
(90:10 DCM/MeOH v/v).  Once the reaction was complete, the solvent was evaporated and the crude 
product purified via silica gel flash column chromatography with a step gradient of methanol (0-10%) in 
dichloromethane.  The final product was isolated as a white solid (755 mg, 88% yield). 
1
H-NMR (400 MHz, CDCl3) δ ppm -0.29 (s, 3H, CH3), -0.22 (s, 3H, CH3), 0.14 (s, 3H, CH3), 0.15 (s, 3H, 
CH3), 0.60 (s, 9H, t-Bu-9H), 0.95 (s, 9H, t-Bu-9H), 1.64 (m, 1H, C2’-H), 2.40 (m, 1H, C2’-H), 3.10 (m, 
1H, C3’-H), 3.82-3.86 (m, 1H, C5’-H), 3.97-4.00 (m, 1H, C5’-H), 4.60 (m, 1H, C4’-H), 5.14 (s, 1H, N
1
-H), 
5.60 (s, 2H, N
2
-2H), 6.46 (t, 1H, C1’-H), 7.60-7.76 (m, 4H, CR-4H), 7.94-7.99 (m, 2H, CR-2H), 8.13 (d, 
1H, CR-H), 8.39 (br. s, 1H, CR-H), 8.68 (d, 1H, CR-H), 8.77 (d, 1H, CR-H), 8.84 (d, 1H CR-H), 9.38 (s, 
1H, N
8
-H)   
13
C-NMR (101 MHz, CDCl3) δ ppm -5.57, -5.47, -4.50, -4.33, 18.24, 18.50, 25.86, 26.00, 29.93, 39.63, 
53.68, 63.33, 68.85, 72.67, 77.08, 77.47, 85.36, 88.34, 100.23, 114.15, 121.15, 122.05, 123.96, 124.07, 
126.47, 126.64, 126.89, 128.02, 128.29, 128.48, 128.56, 130.59, 131.73, 132.60 
ESI-MS (positive mode): m/z calcd for C40H52N6O2Si2H
+
 737.4, observed 737.4 Da [M+H]
+
 
 
8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-N
2
-DMF-2'-deoxyguanosine (12) – In a 50 
mL round bottom flask equipped with a stirbar was taken 11 (755 mg, 1.024 mmol).  The flask was 
placed under a N2 atmosphere.  To it was added anhydrous methanol (15 mL) and the solution was purged 
for 15 mins with N2.  After, N,N-dimethylformamide dimethyl acetal (0.6 mL, 4.097 mmol) was slowly 
added dropwise to the solution.  The solution was stirred was stirred for 40 hr. After the reaction was 
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complete, the solvent was evaporated, and the crude product was purified via silica gel flash column 
chromatography with a step gradient of methanol (0-10%) in dichloromethane to give the pure product as 
a yellow solid in quantitative yield (811 mg, 100% yield). 
1
H-NMR (400 MHz, CDCl3) δ ppm -0.35 (s, 3H, CH3), -0.25 (s, 3H, CH3), 0.09 (s, 6H, 2 x CH3), 0.57 (s, 
9H, t-Bu-9H), 0.91 (s, 9H, t-Bu-9H), 2.27-2.32 (ddd, 1H, C2’-H), 2.78-2.85 (ddd, 1H, C2’-H), 3.07 (s, 3H, 
DMF-CH3), 3.13 (s, 3H, DMF-CH3), 3.82-3.86 (m, 1H, C5’-H), 3.92-3.96 (m, 1H, C5’-H), 4.11 (q, 1H, 
C4’-H), 4.50 (m, 1H, C3’H), 6.49 (t, 1H, C1’-H), 7.56-7.68 (m, 4H, CR-4H), 7.88-7.93 (m, 2H, CR-2H), 
8.08 (d, 1H, CR-H), 8.20 (br. s, 1H, N
1
-H), 8.54 (s, 1H, CR-H), 8.61 (s, 1H, CR-H), 8.76 (t, 2H, CR-2H), 
9.18 (br. s, 1H, N
8
-H) 
13
C-NMR (101 MHz, CDCl3) δ ppm -5.81, -5.72, -4.73, -4.60, 17.94, 18.27, 25.63, 25.73, 31.39, 35.16, 
36.43, 39.82, 41.26, 63.25, 72.68, 84.78, 88.03, 114.41, 120.83, 121.98, 123.72, 124.00, 125.50, 126.07, 
126.17, 126.30, 126.44, 126.48, 128.13, 128.89, 130.28, 131.46, 132.27, 133.89, 147.58, 148.93, 154.68, 
157.26, 162.47 
ESI-MS (positive mode): m/z calcd for C43H57N7O4Si2H
+
 792.4, observed 792.6 Da [M+H]
+
. 
  
8-(N-6-Aminochrysene)-N
2
-DMF-2'-deoxyguanosine (13) – In a 50 mL round bottom flask was taken 
12 (811 mg, 1.024 mmol).  The flask was placed under a N2 atmosphere and to it was added anhydrous 
tetrahydrofuran (25 mL).  To the stirring solution was added 1M tetrabutylammonium fluoride in 
tetrahydrofuran (4.2 mL, 4.116 mmol).  The reaction mixture immediately turned red after this addition.  
The solution was allowed to stir for 15 h under N2.  After this time, the solvent was evaporated and the 
crude product was purified via silica gel flash column chromatography with methanol (0-20%) in 
dichloromethane as the mobile phase.  The pure product was afforded as a pale yellow solid (312.3 mg, 
54% yield).   
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1
H-NMR (400 MHz, DMSO-d6) δ ppm 2.22 (ddd, 1H, C2’-H), 2.98-3.05 (m, 1H, C2’-H), 3.05 (s, 3H, 
DMF-CH3), 3.18 (s, 3H, DMF-CH3), 3.65-3.70 (m, 1H, C5’-H), 3.79-3.85 (m, 1H, C5’-H), 3.94 (m, 1H, 
C4’-H), 4.51 (m, 1H, C3’-H), 5.32 (d, 1H, C3’-OH), 5.44 (t, 1H, C5’-OH), 6.50 (t, 1H, C1’-H), 7.66-7.80 (m, 
4H, CR-3H and DMF-CH), 8.03-8.10 (m, 2H, CR-2H), 8.19 (d, 1H, CR-H), 8.56 (s, 1H, N
1
-H), 8.72 (m, 
2H, CR-2H), 8.86 (d, 1H, CR-H), 9.00 (m, 2H, CR-2H), 11.23 (s, 1H, N
8
-H) 
13
C-NMR (101 MHz, DMSO-d6) δ ppm 13.71, 18.68, 19.72, 23.62, 30.79, 34.94, 46.87, 49.18, 54.99, 
58.23, 62.02, 67.58, 71.86, 84.10, 88.12, 114.15, 116.78, 121.66, 123.82, 124.11, 125.79, 126.61, 126.81, 
127.09, 127.17, 127.49, 128.15, 128.75, 128.90, 130.17, 131.68, 132.66, 136.62, 147.72, 149.71, 156.49, 
157.56, 158.20 
ESI-MS (positive mode): m/z calcd for C31H29N7O4H
+
 564.2, observed 586.3 Da [M+Na]
+
. 
8-(N-6-Aminochrysene)-N
2
-DMF-5’-O-(4,4’-dimethoxytrityl)-2’-deoxyguanosine (14) – The product 13 
of the preceding reaction was thrice azeotroped with anhydrous pyridine.  In a 50 mL round bottom flask 
equipped with a stirbar was taken 13 with 4-dimethylaminopyridine (DMAP, 5 mg, catalytic amt.).  The 
flask was placed under an argon atmosphere, and to it was added anhydrous pyridine (3 mL).  To the 
stirring solution was added 4,4’-dimethoxytrityl chloride (110 mg, 0.325 mmol).  The reaction mixture 
immediately turned a deep orange-yellow.  Within one hour, the reaction mixture darkened to green.  
Over the following 2 hr, the reaction mixture became brown.  The reaction was monitored via TLC 
(94:5:1 DCM/MeOH/NEt3).  The reaction was stopped after 25 h and dried under nitrogen.  The crude 
product was purified via silica gel column chromatography (0-5 % methanol in methylene chloride 
containing 1% NEt3).  The product began eluting at approximately 5%.  The pure product was isolated as 
a pale yellow solid (138 mg, 80% yield).   
1
H-NMR (400 MHz, CDCl3) δ ppm 2.83 (m, 1H, C2’-H), 3.08 (s, 3H, DMF-CH3), 3.24 (s, 3H, DMF-
CH3), 3.27-3.32 (m, 2H, C5’-2H), 3.45 (s, 3H, DMTr-OMe), 3.48 (s, 3H, DMTr-OMe), 3.71 (m, 1H, C4’-
H), 4.80 (m, 1H, C3’-H), 5.29 (s, 1H, C3’-OH), 6.34 (d, 2H, DMTr-2H), 6.38 (d, 2H, DMTr-2H), 6.74 (t, 
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1H, C1’-H), 7.01 (t, 3H, DMTr-3H), 7.07 (d, 2H, DMTr-2H), 7.11 (d, 2H, DMTr-2H), 7.41-7.56 (m, 4H, 
DMF-H, CR-3H), 7.65-7.72 (m, 2H, DMTr-2H), 7.83 (s, 1H, N8-H), 7.87-7.94 (m, 4H, CR-4H), 8.35 (s, 
1H, CR-H), 8.58 (d, 1H, CR-H), 8.74 (m, 2H, CR-2H). 
13
C-NMR (101 MHz, CDCl3) δ ppm 13.22, 14.38, 19.26, 22.86, 23.58, 29.17, 33.81, 34.70, 38.69, 41.06, 
54.41, 54.46, 58.51, 71.03, 83.35, 85.61, 86.01, 112.26, 115.52, 116.74, 119.98, 122.79, 123.46, 125.57, 
126.20, 126.28, 126.44, 126.55, 127.16, 127.85, 128.12, 128.40, 129.24, 129.57, 130.58, 131.45, 133.80, 
134.37, 142.72, 148.45, 149.50, 154.74, 156.38, 157.64, 157.72, 169.86. 
ESI-MS (positive mode): m/z calcd for C52H47N7O6H
+
 866.4, observed 888.6 Da [M+Na]
+
. 
8-(N-6-amino-chrysene)-N
2
-DMF-5’-O-(4,4’-dimethoxytrityl)-3’-cyanoethyl-2’-deoxyguanosine 
phosphoramidite (15) – The entirety of the reaction was completed in a glovebag.  In a 50 mL round 
bottom flask equipped with a stirbar was taken 14 (225 mg, 0.260 mmol) after having been dried 
thoroughly.  The flask was placed under an argon atmosphere, and the product of the previous reaction 
was dissolved in anhydrous methylene chloride (3 mL).  To the stirring solution was added anhydrous 
N,N-diisopropylethylamine (94 μL, 0.538 mmol), followed by 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite (60 μL, 0.260 mmol).  The reaction mixture was allowed to stir for 15 
mins. At this time, additional anhydrous N,N-diisopropylethylamine (94 μL, 0.538 mmol) was added to 
the solution.  The reaction was allowed to stir for an additional 15 mins, at which time it was stopped.  
The solution was diluted with methylene chloride (15 mL) and saturated sodium bicarbonate (20 mL).  
The organic layer was retained and the aqueous layer further extracted with methylene chloride (2 x 20 
mL).  The organic layers were combined and washed with brine (1 x 25 mL).  The organic layer was dried 
over sodium sulfate and the solvent removed by rotary evaporation to give the crude product as a yellow-
brown solid.  This was dissolved in minimal methylene chloride (2 mL) and added dropwise to a stirring 
solution of hexanes (200 mL).  The resulting precipitate was filtered out and collected.  Any remaining 
free phosphorus was removed via basified silica gel flash column chromatography with a step gradient of 
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methanol (0-2%) in methylene chloride containing 1% triethylamine.    The product was isolated as a pale 
yellow solid (145 mg, 52% yield). 
1
H NMR (500 MHz, CDCl3, two diastereomers) δ 1.27 (m, 12H, 4 x 
i
Pr-CH3), 1.71 (m, 1H, C2’-H), 2.36 
(t, 1H, -CH2CN), 2.52 (t, 1H, -CH2CN), 2.60-2.66 (m, 1H, P-O-CH2), 2.75 (td, 1H, P-O-CH2), 3.08 (s, 
3H, DMF-CH3), 3.13 (s, 3H, DMF-CH3), 3.30 (m, 1H, C2’-H), 3.34-3.42 (m, 2H, C5’-2H), 3.47 (s, 3H, 
DMTr-OCH3), 3.48 (s, 3H, DMTr-OCH3), 3.70 (m, 1H, C4’-H), 4.09-4.23 (m, 1H, P-N-CH), 4.30 (m, 1H, 
C3’-H), 4.73-4.84 (m, 1H, P-N-CH), 6.43 (m, 4H, DMTr-4H), 6.53 (t, 1H, C1’-H), 7.06 (m, 3H, DMTr-
3H), 7.09-7.16 (m, 5H, DMTr-5H), 7.29 (m, 2H, DMTr-H, CR-H), 7.43 (m, 2H, CR-H, DMTr-H), 7.51 
(t, 1H, CR-H), 7.65 (t, 1H, CR-H), 7.86 (m, 2H, N
1
-H, CR-H), 7.94 (d, 1H, CR-H), 8.10 (dd, 1H, CR-H), 
8.56 (s, 1H, DMF-CH), 8.59 (dd, 1H, CR-H), 8.65 (d, 1H, CR-H), 8.76 (d, 1H, CR-H), 8.82 (br. s, 1H, 
N
8
-H) 
13
C NMR (101 MHz, CDCl3, two diastereomers) δ 11.44, 14.13, 18.78, 20.11, 20.16, 20.20, 22.67, 22.93, 
23.00, 23.02, 24.52, 24.60, 25.31, 31.61, 34.69, 35.12, 41.18, 43.29, 43.38, 45.32, 45.37, 54.94, 54.96, 
58.14, 58.18, 77.24, 84.02, 86.59, 86.63, 112.85, 112.87, 112.93, 120.76, 122.29, 123.62, 124.02, 126.19, 
126.40, 127.73, 128.37, 128.90, 129.79, 129.87, 129.94, 158.37 
31
P NMR (x MHz, CDCl3, two diastereomers) δ 148.61, 149.09 
ESI-MS (positive mode): m/z calcd for C61H64O7N9P
+
 1066.47 Da, observed 1066.191 Da [M]
+
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2.3 Results and Discussion 
 
For introduction of the bromine at the C8 positon of deoxyguanosine, freshly recrystallized NBS was 
used; crude NBS resulted in lower yields for the reaction.  In the third step of the scheme, which involved 
a Mitsunobu reaction to protect the carbonyl moiety, DIAD was preferentially used in place of DEAD.  
Again, DIAD resulted in better yields for the reaction.  The final protection on the dG is a DMTr 
protection of the free primary amine.  The DMTr group is believed to facilitate the successive Buchwald-
Hartwig coupling reaction.  This is generally attributed to the increased solubility of the dG in the reaction 
as a result of the non-polar DMTr group.   
 
After the Buchwald-Hartwig coupling, all successive products are extremely prone to degradation, as they 
are acid-, light-, temperature-, and pressure-sensitive.  The reactions are wrapped in aluminum foil to 
prevent the products from undergoing photodecomposition.  Also, if the synthesis is paused at any point, 
the product is stored at -20 
o
C to limit the rate of degradation.  At the final stage of the synthesis, the 
phosphoramidite adduct is kept at -80 
o
C and wrapped in foil to prevent degradation.   
 
The Buchwald-Hartwig coupling products are purified via aluminum oxide column chromatography.  
This is done to prevent any degradation that the mildly acidic silica gel could potentially cause.  After this 
however, silica gel is used since the most acid labile group present is the DMTr group.  The DMTr group 
is then cleaved with an extremely dilute solution of HCl; the strength of the acid used is critical since the 
N-glycosidic bond is highly acid-sensitive.  The deprotection of the TBDMS ether groups was carried out 
with 1M TBAF in THF, but this reaction could also be substituted with TEA•3HF.  The final DMTr 
protection of the 5’OH group is a critical step.  The reaction mixture must be very dry in order to succeed 
in the next step; as such, the starting material was thrice-co-evaporated with pyridine.  Additionally, the 
total time of the reaction along with the equivalents of DMT-Cl used was vital.  If a large excess of DMT-
Cl is used, the time must be monitored very carefully to ensure that protection of the 3’-OH does not 
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occur.  A balance of 1.2 equivalents of DMT-Cl allowed the time component to be far less important, and 
given appropriate time, the reaction proceeded in good yield, without an excessive amount of product 
with both hydroxyl groups protected.  The final step, phosphoramidite protection of the 3’-OH is also 
extremely sensitive.  The starting material – which is one of the most stable products (relatively) within 
the scheme – was left to dry overnight under vacuum, to ensure no moisture would be present in the 
reaction.  If this was not possible, the starting material was co-evaporated with methylene chloride 
multiple times and then left to dry under vacuum.  The phosphoramidite reaction itself was performed in a 
glovebag with an argon atmosphere.  The final two reactions were also purified with a basified silica gel 
column; this is to prevent the acidity of the silica gel from interfering with the products that were being 
separated.  The synthesized phosphoramidite adduct is completely characterized (spectra show in the 
following section) and is ready for incorporation into an oligomer via solid-phase oligonucleotide 
synthesis.   
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CHAPTER III 
 
 
SYNTHESIS OF THE N2 
PHOSPHORAMIDITE MONOMER OF N2-
(6-AMINOCHRYSENE)-5’-O-(4,4’-
DIMETHOXYTRITYL)-2’-
DEOXYGUANOSINE 
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3.1 Original Synthetic Scheme for the 6-NC N
2
-dG Adduct 
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3.2 Materials and Methods 
 
MATERIALS 
Please refer to the materials section listed in the previous chapter. 
PROCEDURES 
 
1,2-Dihydronaphtho[2,1-b]furan-1,2-diol (16) – Freshly recrystallized 2-naphthol (2.00 g, 0.0139 mol) 
was added to a stirring Erlenmeyer flask of boiling deionized water (28 mL).  The mixture was allowed to 
stir for 3-5 mins.  To the stirring Erlenmeyer flask was added KOH (0.780 g, 0.0139 mol); the solution 
became homogenous and dark green.  This solution was added dropwise over 1.5 h to a 500 mL round 
bottom flask equipped with a stirbar containing glyoxal (24 mL, 0.209 mol) at 40 
o
C.    The reaction 
mixture was stirred for an additional 3 h.  After this time, the reaction mixture was diluted with CHCl3 
(75 mL) and deionized water (75 mL).  The layers were separated and the aqueous layer was extracted 
with CHCl3 (2 x 75 mL).  The organic layers were combined and washed with brine (1 x 50 mL).  The 
organic layer was retained and dried over sodium sulfate.  The solvent was removed via rotary 
evaporation.  The crude product was purified by silica gel flash column chromatography with a step 
gradient of methanol (0-10%) in methylene chloride as the mobile phase.  The product was isolated as a 
yellow-orange oil (2.30 g, 85% yield). 
 
1
H-NMR (400 MHz, DMSO-d6) δ ppm 5.25 (d, 1H, C12-H), 5.73 (d, 1H, C13-H), 5.86 (d, 1H, O15-H), 7.18 
(d, 1H, C8-H), 7.35 (t, 1H, C2-H), 7.43 (d, 1H, O14-H), 7.53 (t, 1H, C1-H), 7.89 (m, 3H, C3-H, C6-H, C7-H) 
 
13
C-NMR (101 MHz, DMSO-d6) δ ppm 77.51 (C13), 109.52 (C12), 113.23 (C8), 120.34 (C10), 123.36 (C6), 
123.68 (C2), 127.60 (C1), 129.28 (C3), 129.60 (C4), 13.44 (C5), 131.70 (C7), 157.55 (C9) 
 
34 
 
Naphtho[2,1-b]furan-2(1H)-one (17) – In a 500 mL round bottom flask equipped with a stirbar was 
taken 16 (6.923 g, 0.03426 mol), CHCl3 (145 mL), and 3N HCl (175 mL).  The reaction mixture was 
stirred at 50 
o
C for 1 hr.  After this time, the reaction mixture was diluted with CHCl3 (100 mL) and 
deionized water (100 mL).  The layers were separated and the aqueous layer extracted with CHCl3 (2 x 
100 mL).  The organic layers were combined and washed with brine (1 x 50 mL).  The organic layer was 
retained and dried over sodium sulfate.  The solvent was removed via rotary evaporation.  The crude 
product was purified by silica gel flash column chromatography with a step gradient of methanol (0-5%) 
in methylene chloride.  The purified product was isolated as a light pink solid (5.211 g, 83% yield).   
 
1
H-NMR (400 MHz, DMSO-d6) δ ppm 4.18 (s, 2H, C13-2H), 7.47 (m, 2H, C1-H, C8-H), 7.59 (t, 1H, C2-
H), 7.72 (d, 1H, C6-H), 7.95 (m, 2H, C3-H, C7-H) 
 
13
C-NMR (101 MHz, DMSO-d6) δ ppm 32.73 (C13), 112.02 (C8), 118.64 (C10), 124.18 (C6), 125.40 (C2), 
128.05 (C1), 129.56 (C3), 129.64 (C5), 129.79 (C7), 130.72 (C4), 152.21 (C9), 175.59 (C12) 
 
Ethyl 2-(2-hydroxynaphthalen-1-yl)acetate (18) – In a 100 mL round bottom flask equipped with a 
stirbar was taken 17 (0.451 g, 0.00245 mol), ethanol (30 mL, 0.514 mol), and sulfuric acid (5.5 mL, 0.103 
mol).  The reaction was refluxed for 8 hh.  After this time, the mixture was allowed to cool to room 
temperature and then neutralized with aqueous sodium bicarbonate.  The resulting precipitate was filtered 
using a Büchner funnel and washed with cold deionized water to give 18 as a light blue crystalline solid 
(0.5246 g, 93% yield). 
 
1
H-NMR (400 MHz, DMSO-d6) δ ppm 1.18 (t, 3H, C16-3H), 4.05 (s, 2H, C11-2H), 4.09 (q, 2H, C15-H), 
7.20 (d, 1H, C8-H), 7.31 (t, 1H, C1-H), 7.45 (t, 1H, C6-H), 7.76 (m, 3H, C2-H, C5-H, C7-H), 9.80 (C17-H) 
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13
C-NMR (101 MHz, DMSO-d6) δ ppm 14.86 (C16), 31.03 (C11), 60.74 (C15), 113.14 (C10), 118.53 (C8), 
123.02 (C5), 123.28 (C1), 127.01 (C6), 128.68 (C4), 128.97 (C2), 129.06 (C7), 134.25 (C3), 153.68 (C9), 
172.07 (C12) 
 
Ethyl 2-(2-(((trifluoromethyl)sulfonyl)oxy)naphthalen-1-yl)acetate (19) – In a 25 mL round bottom 
flask equipped with a stirbar was taken 18 (0.2868 g, 1.246 mmol).  The flask was placed under an N2 
atmosphere and then cooled to 0 
o
C in an ice bath; it was dissolved dry pyridine (2 mL).  To the stirring 
mixture at 0 
o
C was slowly added triflic anhydride (0.233 mL, 1.385 mmol) dropwise.  After stirring at 0 
o
C for 5 mins, the ice bath was removed and the flask was allowed to warm to room temperature.  The 
reaction mixture was allowed to stir for 25 h at room temperature.  After this time, the solvent was 
removed via rotary evaporation.  The crude product was purified by silica gel flash column 
chromatography with a step gradient of ethyl acetate (0-20%) in hexanes as the mobile phase.  The pure 
product was isolated as a light yellow oil (0.449 g, 99% yield). 
 
1
H-NMR (400 MHz, DMSO-d6) δ ppm 1.16 (t, 3H, C23-3H), 4.10 (q, 2H, C24-2H), 4.28 (s, 2H, C12-2H), 
7.55 (d, C6-2H), 7.69 (m, 2H, C3-H, C7-H), 8.10 (m, 3H, C1-H, C2-H, C8-H) 
 
13
C-NMR (101 MHz, DMSO-d6) δ ppm 14.53 (C23), 32.10 (C24), 61.50 (C12), 117.17 (C15), 119.66 (C8), 
120.34 (C15) 124.00 (C10), 125.63 (C6), 127.84 (C2), 128.62 (C1), 129.34 (C3), 131.20 (C7), 132.93 (C5), 
133.14 (C4), 146.02 (C9), 169.96 (C11) 
 
19
F-NMR (376 MHz, DMSO-d6) δ ppm -73.93 (s, 3F, C15-3F) 
 
Ethyl 2-(2-(2-formylphenyl)naphthalen-1-yl)acetate (20) – In a 25 mL round bottom flask equipped with 
a stirbar was taken 19 (181 mg, 0.5 mmol) and dry dioxane (3 mL); flask was kept under an argon 
atmosphere.  The flask was purged for 1 hr. with argon gas at room temperature.  After this time, 2-
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formyl phenylboronic acid (90 mg, 0.6 mmol), DavePhos (23 mg, 6 mol %), and 
tetrakis(triphenylphosphine)palladium(0) (46 mg, 8 mol %) was added to the flask and heated for an 
additional hour at 90 
o
C.  After this time, cesium carbonate (489 mg, 1.5 mmol) was added to the flask 
and the flask was heated at 100 
o
C for 90 mins.  The reaction was stopped at this time and the flask was 
allowed to cool to room temperature.  The solvent was evaporated and the crude product was purified via 
silica gel flask column chromatography with ethyl acetate (0-20%) in hexanes as the mobile phase.  A 
combination of 20 and 21 were obtained.  The product 21 is sparingly soluble in hexanes, and the 
majority of it was obtained by filtering the combined fractions obtained after column chromatography; 
isolated as a white powder.  The filtrate was collected; the solvent removed via rotary evaporation and the 
resulting green-brown viscous solid (~83.1 mg, ~55% yield) was used in the following reaction to 
generate 21. 
 
1
H-NMR (400 MHz, CDCl3) δ ppm 1.14 (t, 3H, C24-3H), 3.93 (s, 2H, C17-2H), 4.07 (q, 2H, C23-2H), 7.39 
(d, 1H, C8-H), 7.44 (d, 1H, C6-H), 7.57-7.70 (m, 4H, C1-H, C2-H, C13-H, C14-H), 7.87 (d, 1H, C12-H), 7.96 
(d, 1H, C3-H), 8.06 (d, 1H, C15-H), 8.11 (dd, 1H, C7-H), 9.79 (s, 1H, C21-H) 
 
Ethyl chrysene-5-carboxylate (21) – In a 250 mL round bottom flask equipped with a stirbar was taken 
the mixture of 20 and 21 (512 mg, 1.609 mmol) in ethyl alcohol (20 mL).  The flask was heated to 40 
o
C.  
To the stirring solution was added 5% KOH in water (5 mL).  The reaction was monitored by thin layer 
chromatography (TLC) (95:5 CH2Cl2/MeOH, v/v).  After 12 hrs., the reaction mixture was filtered 
through a Büchner funnel.  The desired compound precipitated out of the reaction mixture and was 
isolated as a white solid (329 mg, 68 % yield). 
 
1
H-NMR (400 MHz, DMSO-d6) δ ppm 1.32 (t, 3H, C23-3H), 4.48 (q, 2H, C22-2H), 7.68-7.73 (m, 2H, C3-
H, C17-H), 7.76-7.80 (t, 1H, C16-H), 7.85-7.89 (t, 1H, C2-H), 8.15-8.29 (m, 4H, C4-H, C13-H, C15-H, C18-
H), 8.33 (s, 1H, C7-H), 8.96 (d, 1H, C14-H), 9.00 (d, 1H, C1-H) 
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13
C-NMR (101 MHz, DMSO-d6) δ ppm 14.26 (C23), 62.09 (C22), 121.11 (C14), 123.42 (C1), 125.50 (C8), 
125.90 (C3), 126.69 (C17), 127.08 (C16), 127.29 (C13), 128.51 (C2), 128.61 (C15), 128.75 (C18), 129.42 
(C4), 129.54 (C11), 129.96 (C7), 130.82 (C9), 131.55 (C5), 132.28 (C10), 132.38 (C12), 133.07 (C6), 172.21 
(C19). 
 
Chrysene-5-carboxylic acid (22) – In a 25 mL round bottom flask equipped with a stirbar was taken 21 
(100 mg, 0.333 mmol) dissolved in dioxane (10 mL).  To it was added a solution of LiOH (100 mg, 3.330 
mmol) in deionized water (5 mL).  The reaction mixture was refluxed and stirred vigorously for 3 days.  
Once the reaction was complete, the flask was allowed to cool to room temperature.  The reaction mixture 
was diluted with DI water (25 mL) and methylene chloride.  Any excess starting material was removed 
via extraction of the solution with methylene chloride (1 x 25ml).  The organic layer was retained and 
washed with DI H2O (3 x 50 mL).  The aqueous layers were combined and acidified using 37% 
hydrochloric acid.  The acidified aqueous layer was diluted with diethyl ether (75 mL) and washed with 
DI water (1 x 75 mL).  The aqueous layer was retained and extracted again with ether (3 x 50 mL).  The 
organic layers were combined and washed with brine (1 x 75 mL).  The organic layer was retained, dried 
over sodium sulfate, and the solvent removed via rotary evaporation to give the desired product as a white 
solid (91 mg, 100 % yield). 
 
1
H-NMR (400 MHz, DMSO-d6) 7.65-7.70 (m, 2H, C2-H, C11-H), 7.75 (t, 1H, C3-H), 7.83 (t, 1H, C12-H), 
8.13 (d, 1H, C1-H), 8.19 (d, 2H, C4-H, C10-H), 8.27 (s, 1H, C8-H), 8.48 (d, 1H, C17-H), 8.94 (d, 1H, C13-
H), 8.96 (d, 1H, C16-H), 13.54 (br. s, 1H, -COOH) 
 
13
C-NMR (101 MHz, DMSO-d6) 121.37 (C16), 123.52 (C13), 124.18 (C11), 126.07 (C2), 126.17 (C3), 
126.67 (C17), 127.42 (C12), 128.21 (C4), 128.42 (C1), 128.49 (C15), 128.50 (C10), 128.80 (C7), 129.01 (C5), 
129.02 (C6), 130.25 (C8), 130.36 (C9), 130.44 (C18), 132.45 (C14), 172.56 (C19) 
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Chrysene-5-carbonyl chloride (23) – In a 25 mL round bottom flask equipped with a stirbar was taken 22 
(52 mg, 0.19 mmol).  The flask was placed under an argon atmosphere.  The compound was dissolved in 
anhydrous methylene chloride (15 mL); reaction mixture was cloudy white.  Oxalyl chloride (0.1 mL, 
0.382 mmol) was added to the flask; reaction mixture turned cloudy yellow.  The reaction mixture was 
allowed to stir for 2 hrs. at room temperature.  Upon completion, the reaction mixture became clear.  At 
this point, the solvent was removed via rotary evaporation to give the pure product as a dark yellow solid 
(100% yield is assumed based on yield for the following reaction – the compound was not isolated) 
 
Chrysene-5-carboxamide (24) – In a 25 mL round bottom flask equipped with a stirbar was taken 23 
(55.5 mg, 0.191 mmol).  The flask was placed under an argon atmosphere, and the compound dissolved in 
anhydrous methylene chloride (5 mL).  NH3 was bubbled into the flask, and as the reaction progressed, 
the mixture became increasingly cloudy from its initial clear yellow color.  Upon completion of the 
reaction, the reaction mixture was a cloudy white.  After 2 h, the reaction was stopped, and the solvent 
removed via rotary evaporation to give the pure product as a white solid (52 mg, 100 % yield). 
 
1
H-NMR (400 MHz, DMSO-d6) 6.99-7.25 (br. s (rotomeric effect), 2H, N20-2H), 7.67-7.70 (m, 2H, C2-H, 
C11-H), 7.76 (t, 1H, C3-H), 7.84 (t, 1H, C12-H), 8.14 (m, 1H, C1-H), 8.20 (m, 2H, C4-H, C10-H), 8.28 (s, 
1H, C8-H), 8.47 (d, 1H, C17-H), 8.94 (d, 1H, C13-H), 8.97 (d, 1H, C16-H) 
 
13
C-NMR (101 MHz, DMSO-d6) 
 
2'-deoxyguanosine, anhydrous (26) – In a 250 mL round bottom flask equipped with a stirbar was taken 
2’-deoxyguanosine monohydrate (10 g, 0.0374 mol).  To it was added pyridine (150 mL).  The stirring 
mixture was refluxed for 5 h.  After this time, the solvent was removed via rotary evaporation and the 
resulting dry dG was stored under N2. 
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3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine (27) – In a 250 mL round bottom flask equipped 
with a stirbar was taken 26 (15.003 g, 56.140 mmol) and imidazole (18.265 g, 268.295 mmol).  The flask 
was placed under an N2 atmosphere.  To the flask was added dry DMF (135 mL).  The reaction mixture 
was left to stir at room temperature for 5-10 mins until the solution was homogenous.  At this point, tert-
butyldimethylsilyl chloride (23.246 g, 154.274 mmol); within 5 mins, the solution became transparent.  
The mixture was left to stir at room temperature under an N2 atmosphere for 8 h.  After this time, the 
reaction was quenched with methanol and the solvent removed via rotary evaporation.  The crude product 
was diluted with methylene chloride () and deionized water ().  The layers were separated and the aqueous 
layer was extracted with methylene chloride (2 x 100 mL).  The organic layers were combined and 
washed with brine (1 x 75 mL).  The organic layer was dried over Na2SO4 and the solvent removed via 
rotary evaporation.  The compound was purified by silica gel flash column chromatography with 
methanol (0-5%) in methylene chloride as the mobile phase.  The pure product was isolated as a white 
solid (21.435 g, 77%). 
 
1
H-NMR (400 MHz, DMSO-d6) δ ppm 0.04 (s, 3H, C22-3H), 0.05 (s, 3H, C21-3H), 0.10 (s, 6H, C28-3H, 
C29-3H), 0.87 (s, 9H, C24-3H, C25-3H, C26-3H), 0.89 (s, 9H, C31-3H, C32-3H, C33-3H), 2.20-2.26 (ddd, 1H, 
C13-H), 2.62-2.67 (ddd, 1H, C13-H’), 3.62-3.72 (qd, 2H, C18-2H), 3.80 (m, 1H, C12-H), 4.48 (m, 1H, C16-
H), 6.09-6.12 (t, 1H, C14-H), 6.49 (br. s, 2H, N10-2H), 7.87 (s, 1H, C7-H), 10.63 (s, 1H, N1-H) 
 
13
C-NMR (101 MHz, DMSO-d6) δ ppm -5.53 (C29), -5.48 (C28), -4.97 (C22), -4.79 (C21), 17.70 (C30), 
17.95 (C23), 25.67 (C31, C32, C33), 25.76 (C24, C25, C26), 62.74 (C13), 72.16 (C18), 82.10 (C12), 86.98 (C14), 
116.63 (C16), 121.32 (C5), 134.86 (C7), 150.97 (C4), 153.72 (C2), 156.65 (C6) 
 
O
6
-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine (28) – In a 500 mL flask equipped with 
a stirbar was taken 27 (15.584 g, 31.434 mmol) and triphenylphosphine (14.403 g, 54.915 mmol).  The 
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flask was placed under an N2 atmosphere and to it was added dry dioxane (200 mL).  To the stirring 
reaction mixture at room temperature, benzyl alcohol (5.702 mL, 55.104 mmol) was added.  Diisopropyl 
azodicarboxylate (10.992 mL, 55.827 mmol) was added dropwise to the stirring mixture, which turned to 
a transparent yellow within 15 mins.  The reaction was allowed to continue stirring at room temperature 
for 8 h under the N2 atmosphere.  After this time, the solvent was evaporated.  The crude compound was 
purified by silica gel flash column chromatography with a step gradient of ethyl acetate (0-30%) in 
hexanes as the mobile phase.  The product was isolated as a white solid (8.56 g, 46 % yield).   
 
1
H-NMR (400 MHz, CDCl3) δ ppm 0.07 (s, 3H, C34-3H), 0.08 (s, 3H, C33-3H), 0.10 (s, 6H, C35-3H, C36-
3H), 0.91 (s, 9H, C38-3H, C39-3H, C40-3H), 0.92 (s, 9H, C30-3H, C31-3H, C32-3H), 2.35-2.40 (ddd, 1H, C13-
H), 2.52-2.58 (ddd, 1H, C13-H’), 3.74-3.84 (qd, 2H, C18-2H), 3.96-3.99 (m, 1H, C12-H), 4.57-4.60 (m, 1H, 
C16-H), 5.01 (br. s, 2H, N10-2H), 5.54-5.61 (s, 2H, C20-2H), 6.33 (t, 1H, C14-H), 7.30-7.37 (m, 3H, C23-H, 
C24-H, C25-H), 7.48-7.51 (d, 2H, C22-H, C26-H), 7.93 (s, 1H, C7-H) 
 
13
C-NMR (101 MHz, CDCl3) δ ppm -5.24 (C36), -5.13 (C35), -4.55 (C34), -4.42 (C33), 18.25 (C37), 18.67 
(C29), 26.00 (C38, C39, C40), 26.21 (C30, C31, C32), 41.27 (C13), 63.00 (C18), 68.54 (C20), 72.05 (C12), 84.10 
(C14), 87.96 (C16), 116.07 (C5), 128.25 (C23, C25), 128.55 (C24), 128.61 (C22, C26), 136.52 (C21), 137.99 
(C7), 154.50 (C4), 158.92 (C2), 161.21 (C6) 
 
 
 
 
 
 
 
 
41 
 
3.3 Results and Discussion 
 
The N
2
-dG 6-nitrochrysene adduct is notably different from the C8-dG adduct due to the attachment point 
of the chrysene derivative to the guanine base.  It attaches at the C5 position of the aryl system as opposed 
to the C6 position.  It is this aspect of the adduct that makes the synthesis particularly challenging.  
Chrysene preferentially reacts at the 6 and 12 positions, making the process of putting a moiety at the 5 
position difficult.  After attempting various schemes which generally fell short of producing initial 
reactions with high yield, the scheme listed earlier was decided upon.  High yields for the first few 
reactions are critical, because the scheme is approximately 20 steps long (depending on how the 
remainder of the scheme develops after Buchwald-Hartwig coupling).  An inability to scale up the 
preliminary products would make the entire scheme tedious and in general, not viable for broad 
application.  The other portion of the scheme, focused on development of the deoxyguanosine derivative 
for Buchwald-Hartwig coupling is completed. 
 
In order to achieve putting an aryl bromide at the C5 position of chrysene, attempts were made to simply 
put any functionality at the C5 positon that could later be altered to a bromide.  It is impossible to use 
chrysene as a starting material, since the C5 position cannot compete with the C6 and C12 positions in 
terms of reactivity.  To work around this, a naphthol derivative was employed as a base for eventually 
building the polyaromatic system.
[27]
  In this scheme, β-naphthol was used in conjunction with glyoxal to 
produce a diol, 16.  From this, the diol was oxidized to a lactone, which was successively broken to form 
an ethyl ester.  At this point, the hydroxyl group at the beta position could easily be transformed to a 
triflate.
[28]
  These four reactions worked in excellent yield and served as a solid foundation for the rest of 
the scheme since they are extremely easy to scale-up. 
 
The purpose of creating the triflate is to perform a microwave Suzuki coupling that would ultimately 
create the backbone for the chrysene aromatic ring system.
[29,30]
  This reaction was originally meant to 
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encompass not only the coupling to form the three ring system, but to also go further and cyclize to form 
the fourth ring which would then undergo condensation to form the chrysene ethyl ester, 21 (Figure 13).  
This one-pot reaction has previously been attempted for a phenanthrene system with limited success.
[29]
  
The group achieved their best coupling and cyclization yield with ethyl esters, which is why ethanol was 
chosen to break the lactone.  
 
Figure 13: General Outline of the Suzuki coupling with Major Products 
 
From this, a series of reactions were completed to standardize the reaction (Table 1).  Originally, upon 
attempting the microwave reaction using the conditions outlined, no reaction was observed.  In the 
beginning, Pd(PPh3)2Cl2 was used as the metal catalyst, with three equivalents of base to push the final 
cyclization and condensation.  Proceeding to increase the temperature (Entry 2), the reaction appeared to 
have started to proceed.  Attempts were made to increase the reaction time, in lieu of increasing the 
temperature, but it appeared as though the high temperatures facilitated the initiation of the reaction 
within a short period of time (Entries 3 and 4).  Since difficulties with coupling reactions usually stem 
from the palladium catalyst, a switch was made to Pd(PPHh3)4, a more reactive palladium catalyst.  This 
produced notably higher yields upon increases in temperature and time.  However, it should be noted that 
over time, a mixture a products was observed; the coupling product and the condensed product after 
cyclization.  Due to the high degree of similarity between these two products’ polarities, it is extremely 
difficult to separate them via column chromatography; as such, yields are given as approximate ranges for 
subsequent entries.  Now that the reaction was starting, a higher catalyst loading was used to push it to 
proceeding further.  Although this did work to some extent, it was found that heating at thigh temperature 
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for a long time would cause degradation of the desired product (21).  In fact, 21 would undergo a form a 
decarboxylation and upon purification of the reaction mixture, pure chrysene was obtained.   
Table 1: Standardization of the Suzuki Coupling Reaction in the N
2
-dG Scheme 
 
After observing this, the coupling was switched from a microwave to a batch reaction, which could 
sustain heat at lower temperatures for a longer length of time.  At the time, it was thought that reaction 
might proceed at a lower temperature with the new palladium catalyst; catalyst loading was also increased 
to better facilitate this.  Entry 8 details the reaction conditions for the first batch reaction, which produced 
considerably higher yields.  The Buchwald-Hartwig coupling procedure is similar to this, with the 
exception of the time of addition of the base.  The delay in adding the base is thought to allow for better 
formation of the intermediate complex, which ultimately increase yield.  Applying this thought process to 
the Suzuki coupling (Entries 9-13), it was hoped that the same overall yield increase would occur.  As 
expected, the yield increased an additional 10%.  After seeing these promising results, the catalyst loading 
was dropped slightly to see if there would be a drastic impact on the reaction yield, and the ideal catalyst 
loading was determined to be 8 mol %.  At this time, the duration of the reaction was the final thing that 
was focused on, and 1.5 h after addition of the base was determined to give the maximum yield.  Since all 
*Estimated yield; mixture of products measured 
**Modified protocol used; base added before increase in temperature 1 hour into the 
reaction 
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of these conditions were still producing a mixture of products, and an additional reaction (simple addition 
of base with heat to promote cyclization and condensation) had to be done anyway on the portion of 
product that did not cyclize and condense, the equivalents of base were also cut down to 1.5 
equivalents.
[31]
  This did not seem to affect the overall outcome of the reaction.  It should be noted, that 
with all of the coupling reactions presented in these syntheses, the yield did drop slightly (~5%) when the 
reaction was scaled up significantly.   
 
After standardization of the coupling reaction and subsequent cyclization/condensation, a series of 
reactions were performed to produce an amide.  This was accomplished through a hydrolysis of the ethyl 
ester, formation of an acyl chloride, and finally bubbling of ammonia to produce the amide.  These all 
worked in excellent yield.  It should be noted that the hydrolysis reaction is best done with LiOH as the 
base.
[32]
  Initially, the reaction was attempted with both KOH and NaOH (since they were stronger bases), 
but the reaction did not proceed as readily KOH and took a significantly longer time to proceed with 
NaOH.  In the end, LiOH worked best; this is attributed to the lithium ion being able to better coordinate 
with the oxygens in the ester since lithium is a far smaller ion.  Additionally, the formation of the acyl 
chloride was originally attempted with SOCl2 as a reagent
[33]
, but upon encountering a difficult work-up, 
the reagent was changed to oxalyl chloride.
[34]
  Finally, the bubbling of ammonia
[35]
 was decided upon, to 
avoid the use of more dangerous reagents such as NaNH2.
[36] 
 
Following production of the amide, the rest of the synthesis involved a Hoffman rearrangement and 
degradation to produce an aryl amine, which could then undergo Sandmeyer bromination.  Ultimately, 
this would put a bromine in the desired C5 position on chrysene.  Then, the final reaction reprises the 
nitration reaction which was already done in the prior C8-dG scheme. 
 
The Hoffman reaction proved to be difficult.  After standardizing the reaction, it was clear that a 
multitude of not only the product, but byproducts and starting materials remained in the reaction 
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mixture.
[37]
  Although the product was not isolated, characteristic peaks of the product were present in the 
NMR of the crude reaction mixture.  Workup of the mixture through extractions eliminated the acid 
formed, but the byproducts proved to be extremely difficult to separate out of the mixture.  Silica gel 
column chromatography resulted in the product (and other byproducts) adhering to the solid phase.  This 
was not entirely unsurprising due to the nitroreduction reaction that produced 6-aminochrysene in the 
previous scheme.  It was clear that a portion of the 6-AC did remain on the column.  This was not a 
problem in the prior scheme where the reaction proceeded well, so the majority of the compound came off 
of the plug with a more polar solvent (such as methanol).  However, the Hoffman reaction required a 
proper separation, so the compounds cannot simply be forced off of the column.  In an attempt to reduce 
the attraction of the compound to the stationary phase, the next attempt at purification used basified silica 
gel (using triethylamine).  This did not yield better results.  To eliminate acidity altogether, neutral 
aluminum oxide was used as the stationary phase, and a proper separation was still not achieved. 
 
As detailed in the above paragraph, the Hoffman reaction posed many difficulties, and it was not clear the 
two-step Sandmeyer bromination
[38]
 would work efficiently and in good yield as well.  Further research 
was done to see if these reactions could be circumvented or replaced altogether with higher yielding 
reactions.  An altered scheme is presented in the following sections. 
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3.4 Modified Synthetic Scheme for the 6-NC N
2
-dG Adduct 
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3.5 Materials and Methods 
 
MATERIALS 
Please refer to the listed materials within the previous chapter. 
PROCEDURES 
Chrysen-5-ylmethanol (38) - In an oven-dried 50 mL round bottom flask equipped with a stirbar was 
taken lithium aluminum hydride (20 mg, 0.499 mmol).  The flask was immediately placed under an argon 
atmosphere.  To it was added anhydrous THF (3 mL) and the flask was allowed to stir in an ice bath for 
5-10 mins.  During this time, 21 (100 mg, 0.333 mmol) was dissolved in anhydrous THF and added 
dropwise to the flask containing LAH.  The reaction was allowed to stir under argon at 0 
o
C for 2.5 h.  At 
this time, the flask was taken out of the ice bath.  The white precipitate was filtered off and washed with 
DCM.  The filtrate was diluted with methylene chloride (50 mL) and deionized water (50 mL).  The 
aqueous layer was extracted with methylene chloride (30 mL).  The combined organic layers were 
washed with brine (50 mL).  The organic layer was then dried over sodium sulfate, and the solvent 
removed via rotary evaporation to afford the pure compound as a white solid (86 mg, 100% yield). 
 
1H-NMR (400 MHz, CDCl3) δ ppm 2.11 (br. s., -OH), 5.45 (s, 2H, -CH2), 7.63-7.73 (m, 4H, CR-4H), 7.97-8.03 
(m, 3H, CR-3H), 8.16 (s, 1H, CR-H), 8.75 (dd, 2H, CR-2H), 8.95 (d, 1H, CR-H) 
 
13C-NMR (101 MHz, CDCl3) δ ppm 66.84, 121.51, 123.14, 126.09, 126.22, 126.93, 127.78, 128.18, 128.46, 
129.82, 130.34, 130.47, 131.32, 133.15, 135.45. 
 
Chrysene-5-carbaldehyde (39) – To a 500 mL round bottom flask equipped with a stirbar was taken # 
(532 mg, 2.060 mmol) in methylene chloride (400 mL); the amount of solvent was maximized to increase 
the speed of the reaction.  To the stirring mixture was added 4-(acetylamino)-2,2,6,6-tetramethyl-1-oxo-
piperidinium tetrafluoroborate (Bobbitt’s Salt, 618 mg, 2.060 mmol).  Upon addition of Bobbitt’s salt, the 
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mixture immediately turned a bright yellow.  Following this, silica gel (532 mg, 1 wt. eq. to alcohol) was 
added to the mixture.  The solution was allowed to stir for 10 h.  The reaction was monitored by TLC 
(neat methylene chloride) and upon completion, the reaction mixture turned clear and translucent.  When 
the reaction was complete, the solution was filtered through a silica gel plug with neat methylene chloride 
to afford the product as a white solid (522 mg, 95% yield).   
 
1H-NMR (400 MHz, CDCl3) δ ppm 7.74-7.91 (m, 3H, CR-3H), 8.12-8.21 (m, 4H, CR-4H), 8.50 (s, 1H, CR-H), 
8.81 (dd, 2H, CR-2H), 10.68 (s, 1H, -CHO) 
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3.6 Results and Discussion 
 
Initially, the scheme called for 5-bromo-6-nitrochrysene as a coupling substrate for the Buchwald-
Hartwig coupling.  Due to difficulties encountered in that scheme, the reactant was altered to have a 
triflate moiety in place of the bromide.  The use of a triflate for a Buchwald-Hartwig coupling between a 
PAH and a DNA nucleoside is very uncommon.
[39]
  An amino group with an aryl bromide has been 
almost exclusively used in most syntheses of this type.  However, there have been many precedents in 
general for joining aryl triflates and amino groups via Buchwald-Hartwig couplings.
[40]
  Based on this, the 
new scheme was conceived to circumvent both the Hoffman degradation and Sandmeyer bromination 
reactions. 
 
Starting from the ethyl 5-chrysene carboxylate, a lithium aluminum hydride reduction was performed to 
produce the corresponding alcohol.
[41]
  This reaction worked in excellent yield, without any need for 
column chromatography purification.  Following this, the product was oxidized to the corresponding 
aldehyde.  Oxidation was accomplished with Bobbitt’s salt, an oxoammonium salt which is known to be 
particularly environmentally friendly.
[42]
  It avoids the use of toxic metal catalysts such as PCC and PDC 
(both chromium-containing reagents), which can contaminate water supplies, interfere with plant 
physiological processes such as photosynthesis, and cause soil erosion.
[43]
  Taking an experimental 
viewpoint, the PCC/PDC approach also involves a monotonous reaction work-up.  From a synthetic 
standpoint, the reaction is excellent because it is a colorimetric process and upon completion, can be 
purified with a simple silica gel plug.  The reaction initially is golden-yellow in color, which  
progressively turns lighter.  Once complete, the reaction becomes clear and translucent.   
 
The subsequent reaction, taking an aromatic aldehyde to an alcohol moiety directly off of the aryl ring 
with loss of one carbon, is far more complex.
[44]
  Standardization of this reaction is currently underway.  
Initial attempts to conduct the reaction at room temperature yielded very slow formation of a product (not 
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isolated, due to the small amount generated).  Another attempt at the reaction, in refluxing conditions  to 
produce more product at a faster rate, resulted in a complex mixture of products.  Currently,  I am 
attempting to identify the compounds resulted from this reaction.  Additional studies will be conducted at 
a slightly elevated temperature to reduce the amount of byproducts. 
 
The successive steps in the production of the 5-trifluoromethanesulfonate-6-nitrochrysene are expected to 
proceed readily and in good yield.  The nitration reaction will be adapted from the C8 chrysene scheme 
detailed in the previous chapter and the triflate formation will be performed in the same manner as 
provided earlier in this scheme. 
 
Following this, the Buchwald-Hartwig coupling reaction is expected to work well owing  to the presence 
of the nitro group on the aryl reactant.  Since the aryl halide/triflate is meant to be “nucleophilic” in nature 
while the organometallic compound is generally “electrophilic” in nature, the presence of electron-
withdrawing groups on the aryl halide/triflate should enhance the efficiency of the coupling reaction.  
This effect is mainly attributed to the oxidative portion of the catalytic cycle, which proceeds faster when 
the palladium catalyst adds into electron-deficient aryl systems.  
 
The remaining series of de-protections and re-protections to form a DNA adduct suitable for solid-phase 
oligonucleotide synthesis should work well.  The only problem that is anticipated is the concurrent 
reduction of the benzyl ether and nitro groups.  This reaction typically only serves to deprotect the 
carbonyl by reducing the benzyl ether protecting group.  However, it is expected to work for both groups.  
In the case that it does not work or does not work efficiently, hydrazine and potentially mild heat will be 
used.  The second approach has been proven to work efficiently and in good yield in literature.  A major 
problem though is the addition of heat. Assuming that the N
2
 adduct is as unstable to light, heat, and acid 
as the C8 adduct was, it would be preferred if the reaction could be accomplished without the addition of 
heat.  In a broad outlook on the scheme with the unstable nature of the compounds in mind, it is also 
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recommended that the scheme not be halted at any point after the Buchwald-Hartwig coupling.  Due to 
the sensitive nature of the components, if the scheme must the paused, it is highly recommended that the 
products be kept sealed, under argon, wrapped in aluminum foil (to prevent light exposure) within -20 
o
C 
(if only overnight) or preferably, -80
 o
C (if for a period of time exceeding 12 h).   
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CHAPTER IV 
 
 
CONCLUSION AND FUTURE WORK 
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Conclusion 
 
These syntheses were designed and carried out to enable biological studies aimed toward understanding 
the initiation phase of cancer.  These studies of the carcinogens are critical, since 6-nitrochrysene, though 
not as prevalent in the atmosphere as some of the other carcinogens, has been proven to be one of the 
most potent carcinogens of the PAH family.  This work entails the syntheses of two 6-nitrochrysene 
deoxyguanosine adducts using a total synthesis approach. 
 
The first adduct, C8-dG, has been completed in its entirety.    The Buchwald-Hartwig coupling reaction 
was successful in forming the C-N bond between 6-aminochrysene and protected 8-bromo-dG.  The C8-
CR-dG phosphoramidite monomer has been prepared, and  solid-phase oligonucleotide synthesis of a 12-
mer has been completed.   
 
The second project detailed was the N
2
-dG project.  The protected dG precursor has already been 
prepared and an outline for the projected scheme up to the phosphoramidite monomer has been planned 
and outlined.  Thus far in the projected scheme, there are three steps left before the chrysene derivative 
for coupling will be prepared.  The coupling is expected to occur in good yield, and the subsequent steps 
are also expected to proceed readily.   
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Future Work 
 
The C8-CR-dG phosphoramidite has been used for oligonucleotide synthesis.  (Figure 14): 
 
 
 
The 12-mer is a sequence from the p53 gene, a tumor suppressor gene.  This gene contains a mutational 
hotspot in the codon 273, where the adduct is located - the “X” in Figure 14.  Mutations in these 
sequences have been detected in human cancers.  So the adducted oligonucleotide will be a valuable 
substrate for  biological and structural studies.  The oligonucleotide will be incorporated into a vector 
which can be utilized in studies of both prokaryotic and eukaryotic cells.  In these studies, the 
mutagenicity of the adduct will be determined. In addition, the roles played by various TLS polymerases 
will be investigated. 
 
In the N
2
-CR-dG adduct work, the reaction to produce 5-hydroxychrysene will soon be standardized.  The 
remaining two steps are expected to proceed readily as they have been completed before in prior schemes 
using reasonable facsimiles of the starting materials in the N
2
-CR-dG scheme.  Also, research is being 
done to ascertain alternate routes of nitroreduction without the use of heat, in case the standard palladium-
catalyzed hydrogenation does not also work to reduce the nitro group in a later reaction of the scheme.  In 
a final attempt to overcome this problem, an additional step can be added to the scheme which will 
separately reduce the nitro group on the chrysene ring system.  As the synthesis already contains 20 
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synthetic steps, this alternative will be only be used as a last resort.  Aside from these two reactions, all 
other steps should result in good yield.  Once the phosphoramidite monomer of the N
2
-CR-dG adduct is 
prepared, it too will be used for solid-phase synthesis.   
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NMR AND MASS SPECTRA FOR  
C8-CR-DG ADDUCT 
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Figure 15: 1H-NMR of 6-Nitrochrysene 
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Figure 16: 1H-NMR of 6-Aminochrysene 
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Figure 17: 13C-NMR of 6-Aminochrysene 
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Figure 18: 1H-NMR of 8-Bromo-2’-deoxyguanosine 
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Figure 19: 13C-NMR of 8-Bromo-2’-deoxyguanosine 
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Figure 20: 1H-NMR of 8-Bromo-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine 
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Figure 21: 13C-NMR of 8-Bromo-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine 
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Figure 22: 1H-NMR of O6-Benzyl-8-bromo-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine 
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Figure 23: 13C-NMR of O6-Benzyl-8-bromo-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine 
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Figure 24: 
1
H-NMR of O
6
-Benzyl-8-bromo-3',5'-O-bis(tert-butyldimethylsilyl)-N
2
-dimethoxytrityl-
2'-deoxyguanosine 
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Figure 25: 
13
C-NMR of O
6
-Benzyl-8-bromo-3',5'-O-bis(tert-butyldimethylsilyl)-N
2
-dimethoxytrityl-
2'-deoxyguanosine 
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Figure 26: 1H-NMR of 8-(N-6-Aminochrysene)-O6-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-N2-
dimethoxytrityl-2'-deoxyguanosine 
73 
 
 
 
Figure 27: 13C-NMR of 8-(N-6-Aminochrysene)-O6-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-N2-
dimethoxytrityl-2'-deoxyguanosine 
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Figure 28: Mass Spectrum of 8-(N-6-Aminochrysene)-O6-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-
N
2
-dimethoxytrityl-2'-deoxyguanosine 
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Figure 29: 1H-NMR of 8-(N-6-Aminochrysene)-O6-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-2'-
deoxyguanosine 
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Figure 30: 13C-NMR of 8-(N-6-aminochrysene)-O6-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-2'-
deoxyguanosine 
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Figure 31: Mass Spectrum of 8-(N-6-Aminochrysene)-O6-benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-
2'-deoxyguanosine 
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Figure 32: 1H-NMR of 8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine 
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Figure 33: 13C-NMR of 8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine 
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Figure 34: Mass Spectrum of 8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-2'-
deoxyguanosine 
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Figure 35: 1H-NMR of 8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-N2-DMF-2'-
deoxyguanosine 
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Figure 36: 13C-NMR of 8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-N2-DMF-2'-
deoxyguanosine 
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Figure 37: Mass Spectrum of 8-(N-6-Aminochrysene)-3',5'-O-bis(tert-butyldimethylsilyl)-N2-DMF-2'-
deoxyguanosine 
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Figure 38: 1H-NMR of 8-(N-6-Aminochrysene)-N2-DMF-2'-deoxyguanosine 
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Figure 39: 13C-NMR of 8-(N-6-Aminochrysene)-N2-DMF-2'-deoxyguanosine 
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Figure 40: Mass Spectrum of 8-(N-6-Aminochrysene)-N2-DMF-2'-deoxyguanosine 
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Figure 41: 1H-NMR of 8-(N-6-Aminochrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-2’-
deoxyguanosine 
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Figure 42: 13C-NMR of 8-(N-6-Aminochrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-2’-
deoxyguanosine 
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Figure 43: Mass Spectrum of 8-(N-6-Aminochrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-2’-
deoxyguanosine 
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Figure 44: 1H-NMR of 8-(N-6-Aminochrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-3’-cyanoethyl-2’-
deoxyguanosine phosphoramidite 
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Figure 45: 13C-NMR of 8-(N-6-Aminochrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-3’-cyanoethyl-2’-
deoxyguanosine phosphoramidite 
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Figure 46: 31P-NMR of 8-(N-6-Aminochrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-3’-cyanoethyl-2’-
deoxyguanosine phosphoramidite 
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Figure 47: Mass Spectrum of 8-(N-6-Aminochrysene)-N2-DMF-5’-O-(4,4’-dimethoxytrityl)-3’-
cyanoethyl-2’-deoxyguanosine phosphoramidite 
Molecular Weight: 1066.191 
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NMR AND MASS SPECTRA FOR  
N2-CR-DG ADDUCT 
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Figure 48: 1H-NMR of 1,2-Dihydronaphtho[2,1-b]furan-1,2-diol 
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Figure 49: 13C-NMR of 1,2-Dihydronaphtho[2,1-b]furan-1,2-diol 
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Figure 50: Mass Spectrum of 1,2-Dihydronaphtho[2,1-b]furan-1,2-diol 
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Figure 51: 1H-NMR of Naphtho[2,1-b]furan-2(1H)-one 
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Figure 52: 13C-NMR of Naphtho[2,1-b]furan-2(1H)-one  
100 
 
 
Figure 53: Mass Spectrum of Naphtho[2,1-b]furan-2(1H)-one 
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Figure 54: 1H-NMR of Ethyl 2-(2-hydroxynaphthalen-1-yl)acetate 
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Figure 55: 13C-NMR of Ethyl 2-(2-hydroxynaphthalen-1-yl)acetate 
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Figure 56: Mass Spectrum of Ethyl 2-(2-hydroxynaphthalen-1-yl)acetate 
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Figure 57: 1H-NMR of Ethyl 2-(2-(((trifluoromethyl)sulfonyl)oxy)naphthalen-1-yl)acetate 
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Figure 58: 13C-NMR of Ethyl 2-(2-(((trifluoromethyl)sulfonyl)oxy)naphthalen-1-yl)acetate 
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Figure 59: 19F-NMR of Ethyl 2-(2-(((trifluoromethyl)sulfonyl)oxy)naphthalen-1-yl)acetate 
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Figure 60: Mass Spectrum of Ethyl 2-(2-(((trifluoromethyl)sulfonyl)oxy)naphthalen-1-yl)acetate 
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Figure 61: 1H-NMR of Ethyl 2-(2-(2-formylphenyl)naphthalen-1-yl)acetate 
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Figure 62: 1H-NMR of Ethyl chrysene-5-carboxylate 
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Figure 63: 13C-NMR of Ethyl chrysene-5-carboxylate 
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Figure 64: Mass Spectrum of Ethyl chrysene-5-carboxylate 
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Figure 65: 1H-NMR of Chrysene-5-carboxylic acid 
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Figure 66: 13C-NMR of Chrysene-5-carboxylic acid 
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Figure 67: 1H-NMR of Chrysene-5-carboxamide 
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Figure 68: 1H-NMR of 3',5'-O-Bis(tert-butyldimethylsilyl)-2'-deoxyguanosine 
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Figure 69: 13C-NMR of 3',5'-O-Bis(tert-butyldimethylsilyl)-2'-deoxyguanosine 
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Figure 70: 1H-NMR of O6-Benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine 
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Figure 71: 13C-NMR of O6-Benzyl-3',5'-O-bis(tert-butyldimethylsilyl)-2'-deoxyguanosine 
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Figure 72: 1H-NMR of Chrysen-5-ylmethanol 
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Figure 73: 13C-NMR of Chrysen-5-ylmethanol 
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Figure 74: Mass Spectrum of Chrysen-5-ylmethanol 
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Figure 75: 
1
H-NMR of Chrysene-5-carbaldehyde 
